Related Experiment Videos
Oxygen supplementation and cardiac-autonomic modulation in COPD
M N Bartels1, J M Gonzalez, W Kim
1Human Performance Laboratory, Presbyterian Hospital of the New-York Presbyterian Hospital, New York, NY 10032, USA. mnb4@columbia.edu
Chest
|September 16, 2000
Summary
Supplemental oxygen therapy in COPD patients improves autonomic nervous system function and baroreflex sensitivity. This study shows that breathing 31% oxygen favorably alters autonomic modulation, benefiting COPD management.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Autonomic Neuroscience
Background:
- Patients with Chronic Obstructive Pulmonary Disease (COPD) exhibit heightened sympathetic nervous system activity and diminished baroreflex sensitivity (BRS).
- Autonomic dysfunction is a significant concern in COPD management.
Purpose of the Study:
- To investigate the impact of breathing 31% supplemental oxygen (SuppO2) on autonomic modulation in individuals diagnosed with COPD.
- To assess changes in heart rate variability and baroreflex sensitivity during oxygen supplementation.
Main Methods:
- A counterbalanced crossover design was employed with 51 COPD patients.
- Autonomic modulation was assessed using time-frequency analysis of R-R intervals and blood pressure (BP) variability before and during SuppO2 administration.
- Baroreflex sensitivity (BRS) was determined using the sequence method.
Main Results:
- Breathing SuppO2 led to significantly higher oxygen saturation levels (96.4% vs. 92.8%) compared to compressed air (CA).
- SuppO2 administration resulted in increased high-frequency modulation (HFln) and BRS, alongside a reduced low-frequency/high-frequency ratio, indicating improved parasympathetic activity.
- Mean heart rate and arterial pulse pressure were significantly decreased with SuppO2 compared to CA.
Conclusions:
- Supplemental oxygenation in COPD patients significantly improves autonomic modulation.
- These findings suggest a favorable alteration in autonomic nervous system function with oxygen therapy in COPD.